Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase II and Pharmacokinetic Study of Avastin and Doxil in the Treatment of Platinum-resistant or Refractory Ovarian Cancer

NCT00846612 is registered in ClinicalTrials.gov with NYU Langone Health as lead sponsor.

NCT NCT00846612
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00846612 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase II and Pharmacokinetic Study of Avastin and Doxil in the Treatment of Platinum-resistant or Refractory Ovarian Cancer
Lead sponsor
NYU Langone Health
Phase
Phase 1
Overall status
Completed
Start date
January 31, 2008
Completion date
June 30, 2012
Enrollment
15 (actual)
Sites
4

Conditions

As the registry lists them; a condition with its own page is linked.

ovarian cancer